Company intelligence / Profile preview

Neoss

Zurich, Switzerland

Ownership: Private
Development stage: Other

Overview

Neoss’s clinical results include over 10 years of clinical data and a 98.6% survival rate for their ProActive Implant system, indicating secure and predictable placement even in challenging cases

Therapeutic areas: Other
Modalities: DeviceBiologicDigital solution
Industry: Implantable Medical Devices

Partnerships

ARC (CAD/CAM production)possible collaborations with dental clinics and labs

Beyond the preview

Go deeper on Neoss.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neoss.

Explore the full profile